6Rubler S, Dlugash J,Yueeoglu YZ, et al. New type of car- diomyopathy associated with diabetic glomerulosclerosis [J]. Am J Cardiol,1972,30(6):5954502.
7Asbun J, Villarreal FJ. The pathogenesis of myocardial fi- brosis in the setting of diabetic cardimyopathy [ J ]. Am Coll Cardio,2006,47 (4) :693-700.
8Golfman LS, Wilson CR, Shama S, et al. Activation of par- gamma enhances myocardial glucose oxidation and im- proves contractile function in isolated working hearts of ZDF rats [ J ]. Am J Physiol Endocrinol Metab, 2005,289 ( 2 ) : E328-E336.
9Aneja A, Tang WH, Bansiinl S, et al. Diabetic cardiomy- opathy:insights into pathogenesis. Diagnostic challenges. and therapeutic options [ J ]. Am J Med, 2008,121 ( 9 ) : 748-757.
10Van den Bergh A, Vanderper A, Vangheluwe P, et al. Dyslipidaemia in type II diabetic mmice does not aggravate contractile impairment but increases ventricular stiffness [ J ]. Cardiovasc Res,2008,77 (2) : 371-379.
